Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value
Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...
SignalSCV20h
The Santa Clarita Valley Signal | #1 source for breaking and local news
Filled with the top stories to start your day, and emergency news alerts.
Indiatimes17h
GSK Pharma - GlaxoSmithKline Pharmaceuticals Share Price
Company has Deloitte Haskins & Sells LLP as its auditors. As on 30-06-2024, the company has a total of 16.94 Crore shares outstanding.GSK Pharma Share Price Today is Rs. 2539.30 as on 11 Nov, 2024, 03 ...
Rotten Tomatoes14h
New Movies in Theaters (2024)
Best TV Shows of 2024: Best New Series to Watch Now Link to Best TV Shows of 2024: Best New Series to Watch Now Best Movies of 2024: Best New Movies to Watch Now Link to Best Movies of 2024 ...